neoplasm
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes
(J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age
(J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma
(J:160299)
• 13% of mutants develop osteochondromyoxoma
(J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate
(J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies
(J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts
(J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells
(J:166728)
|
• rare development of metastatic osteochondrosarcomas
|
• rare chondromas in the long bones
|
skeleton
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes
(J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age
(J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma
(J:160299)
• 13% of mutants develop osteochondromyoxoma
(J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate
(J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies
(J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts
(J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells
(J:166728)
|
• rare development of metastatic osteochondrosarcomas
|
• rare chondromas in the long bones
|
• overall bone mineralization density is lower than in wild-type mice
|
• in affected bones, normal cortical bone is replaced by mineralized material
|
• periosteum of affected bones is abnormal, with occasional cells from lesions crossing the periosteum into the extraosseous space and Sharpey fibers, characteristic of fibrous dysplasia, are observed
|
• although the bone marrow is expanded by active osteoclastic activity, these cells are not able to mature into osteoblasts and mineralize the matrix resulting in undermineralization
• bones exhibit a lag between bone matrix formation and mineralization and abnormal coordination of these processes with bone resorption
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
CINCA Syndrome | DOID:0090029 |
OMIM:607115 |
J:166728 |